Episode 24: Afrezza User

If every there was a rock star diabetes drug, Afrezza is it.

In this episode Corinna Cornejo speaks with Emily Coles about how the inhalable insulin Afrezza has captured the imagination of the diabetes patient community and its impact on the diabetes treatment landscape.

We also share highlights from a live interview with Sam Finta, aka AfrezzaUser. Sam spent years being as careful as possible and feeling like “giving up” on his diabetes. Severe depression and anxiety inspired him to seek better means of diabetes treatment. He was fortunate to obtain one of the last openings in MannKind’s Afrezza drug trial in Atlanta through Dr. Bruce Bode of the Atlanta Diabetes Center. Since then, Sam has provided honest, genuine, and truthful information about his experiences with Afrezza via social media ( on Yahoo message Boards, blogspots and others) .

You can find the complete interview with Sam Finta in our archives.

Everybody Talks Diabetes Podcast Corinna Cornejo

Share This:


Sam Finta, “AfrezzaUser” Talks About Inhalable Insulin

Published on May 7, 2015

Sam Finta, aka AfrezzaUser, spent years being as careful as possible and feeling like “giving up” on his diabetes. Severe depression and anxiety inspired him to seek better means of diabetes treatment, and he was fortunate to obtain one of the last openings in MannKind’s Afrezza drug trial in Atlanta through Dr. Bruce Bode of the Atlanta Diabetes Center.

Immediately and from day one, Sam’s felt his life was changed for the better. Since then, he has done his best through social media (Yahoo message Boards, blogspots and others) to provide honest, genuine and truthful information about his experience with Afrezza. He credits it with saving his life and giving him hope as he wait with countless other people with diabetes to have a near “normal” life again. This is what started Sam’s desire to reach other people with diabetes with his firsthand knowledge of Afrezza.